D-0946-2023 Class II

Recalled by The Ritedose Corporation — Columbia, SC

FDA drug recall D-0946-2023 was initiated by The Ritedose Corporation on Jul 21, 2023 and is designated Class II. Reason for recall: CGMP deviation: product released prior to supplier approval. Affected quantity: 44 cartons.

Recall details

Product Type
Drugs
Report Date
Aug 9, 2023
Initiation Date
Jul 21, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44 cartons

Product description

Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not For Inhalation or Injection, Must be Diluted, Manufactured by: The Ritedose Corporation Columbia, SC 29203 for Ritedose Pharmaceuticals, LLC Columbia, SC 29203, NDC 76204-025-96.

Reason for recall

CGMP deviation: product released prior to supplier approval.

Distribution pattern

Nationwide in the US

Code information

Lot: 23CE2, Exp. 03/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0946-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0946-2023. Report a data issue: hello@regdatalab.com.